“At present, neurodegenerative diseases represent one of the main causes of death in the industrialized economy. Overall characterized by a loss of neurons in particular regions of the nervous system, the subsequent decline in cognitive and motor function that patients experience in these diseases is associated with nerve cell loss.” – Emerging Therapeutics for Neurodegenerative Diseases, Part I: Novel Targeted Therapeutic Strategies Technologies for Alzheimer’s and Parkinson’s Diseases Frost & Sullivan
- Neurology Market: A BCC Research Overview (Aug 2019)
- Latest Innovations in Medical Device Technologies (Aug 2019)
- Neurology Market: A BCC Research Overview (Aug 2019)
- Innovations for the Management of Cancer, Cardiovascular, and Neurological Diseases (Sep 2019)
- Emerging Therapeutics for Neurodegenerative Diseases, Part I: Novel Targeted Therapeutic Strategies Technologies for Alzheimer’s and Parkinson’s Diseases (Aug 2019)
- Growth Opportunities in the Neurodegenerative Disorder Therapeutics Market, Forecast to 2024 (Aug 2019)
- Global; Technology Innovation Award – Autism and Parkinson’s Disease Microbiome-based Therapeutics (December 2018)
- Advancements in Parkinson’s Disease Therapy, Medical Diagnostics, Wood Waste Recycling, High-tech Materials, and Organ Preservation (April 2018)
- Systematic Audiological Assessment of Auditory Functioning in Patients With Parkinson’s Disease.
By: De Keyser, Kim; De Letter, Miet; De Groote, Evelien; Santens, Patrick; Talsma, Durk; Botteldooren, Dick; Bockstael, Annelies. Journal of Speech, Language & Hearing Research. Dec2019, Vol. 62 Issue 12, p4564-4577. 14p. 10 Charts, 2 Graphs, 1 Map. DOI: 10.1044/2019_JSLHR-H-19-0097. , Database: Business Source Corporate Plus
- Intelligent cyber-physical system for an efficient detection of Parkinson disease using fog computing.
By: Devarajan, Malathi; Ravi, Logesh. Multimedia Tools & Applications. Dec2019, Vol. 78 Issue 23, p32695-32719. 25p. DOI: 10.1007/s11042-018-6898-0. , Database: Business Source Corporate Plus
- Extraction, selection and comparison of features for an effective automated computer-aided diagnosis of Parkinson’s disease based on [123I]FP-CIT SPECT images.
By: Oliveira, Francisco P. M.; Faria, Diogo Borges; Costa, Durval C.; Castelo-Branco, Miguel; Tavares, João Manuel R. S. European Journal of Nuclear Medicine & Molecular Imaging. Jun2018, Vol. 45 Issue 6, p1052-1062. 11p. 3 Color Photographs, 1 Black and White Photograph, 1 Diagram, 3 Charts, 1 Graph. DOI: 10.1007/s00259-017-3918-7. , Database: Business Source Corporate Plus
Clients can view Datamonitors’ reports on the in-depth analysis of the Parkinson’s disease market. Reports are divided into different sections including the treatment, forecast, pipeline, and marketed drugs of the disease.
Clients can view the latest industry briefs and industry trend analyses of the market with BMI/Espicom. With the MedTrack database, clients can search research and development spending and view company details and financials.
Further you research with some of the following reports available from our various resources.
Clients can view the list of databases the Market Research Centre has access to here.
If you would like to view any of the above reports or, if you have any queries, contact us at market.research@enterprise-ireland.com or 01 727 2324. The Market Research Centre is open Monday to Friday from 9am to 5pm.
Important Note: All databases are subject to copyright. The use of cameras and USBs is strictly prohibited.